CPK Earnings

CPK reported its earnings on 2026-02-25, showcasing a revenue of against an estimate of 208.59M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 2.06 by 0%. The stock experienced a 0.28% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CPK's earnings announcement on 2026-02-25, the stock price moved by 0.28% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CPK's stock price tends to shift by an average of -0.76% in the 10 days leading up to earnings and -0.59% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate CPK's annual revenue to reach 328.51M, while the EPS is projected at 2.46. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CPK's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CPK's stock price typically moves by -0.76% in the 10 days before its earnings and -0.59% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 2.46 and revenue of 328.51M.

The earnings call summary reflects a positive sentiment due to strong financial metrics, optimistic long-term guidance, and strategic investments. The Q&A section highlights management's confidence in growth and resilience, despite some vague responses. The reaffirmed EPS guidance, increased capital expenditure, and dividend growth suggest positive stock movement. The market cap indicates moderate volatility, leading to a positive prediction (2% to 8%) over the next two weeks.